Cancer immunotherapy: Targeting regulatory T cells

Comment

Sarah Crunkhorn. Nat Rev Drug Discov. 2017.

. 2017 Oct 30;16(11):754.

doi: 10.1038/nrd.2017.206.

No abstract available

Comment on

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RHI, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV. Ribas A, et al. Cell. 2017 Sep 7;170(6):1109-1119.e10. doi: 10.1016/j.cell.2017.08.027. Cell. 2017. PMID: 28886381 Free PMC article. Clinical Trial.
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.
Brown MC, Holl EK, Boczkowski D, Dobrikova E, Mosaheb M, Chandramohan V, Bigner DD, Gromeier M, Nair SK. Brown MC, et al. Sci Transl Med. 2017 Sep 20;9(408):eaan4220. doi: 10.1126/scitranslmed.aan4220. Sci Transl Med. 2017. PMID: 28931654 Free PMC article.